Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.
News|Articles|June 5, 2020
Image IQ: Superficial lesion on right upper back
Author(s)Dermatology Times Staff
A middle-aged male patient with a superficial lesion on right upper back.
Advertisement
Vascular-specific lasers have been increasingly studied for the treatment of basal cell carcinoma (BCC), specifically for non-aggressive BCCs, including the superficial and nodular subtypes, and may achieve good outcomes, according to Jusleen Ahluwalia, M.D., Mathew Avram, M.D., and Arisa Ortiz, M.D., department of dermatology, University of California, San Diego Health, La Jolla, Calif., and Massachusetts General Hospital, Boston. They published a review in the journal Dermatologic Surgery that examined the role of laser therapy for BCC.
Advertisement
Related to this article
Dermatology Times is looking back on the top stories in dermatology from the month of October.
From “Botox in a bottle” to castor oil and face taping, Dermatology Times reviews the evidence behind 3 viral dermatology trends from October.
Dermatology PAs unpack 4 frightening skin care myths and trends, from sunscreen misinformation and citrus DIYs to overusing actives and beef tallow.
The approval expands the IL-23 inhibitor’s indications beyond moderate-to-severe plaque psoriasis to include adults with active psoriatic arthritis.
Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of October.
Clinician FAQ on remibrutinib's FDA approval in symptomatic dermographism: RemIND efficacy, mechanism, safety, and supporting CSU evidence.
Elevate-Derm Summer 2026 faculty share practical lessons on hair loss exams, PIH, geriatric dermatology, and managing cholesterol rises on JAK inhibitors.
Advertisement
Advertisement